Why The DEA’s Interim Rule On Hemp-Derived Cannabinoids Is Bad For The Industry
Why The DEA’s Interim Rule On Hemp-Derived Cannabinoids Is Bad For The Industry
The regulatory gap that skips over hemp processing is relevant to understand the danger of the DEA’s interim rule and how it is inconsistent with the 2018 Farm Bill.
The post Why The DEA’s Interim Rule On Hemp-Derived Cannabinoids Is Bad For The Industry appeared first on The Fresh Toast.